Clinical trial · Interventional
Kid Cards: Teaching Kids About Medicines
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Not completed
Summary
Brief summary (as posted)
This study is being done to see if education about medicines directed toward children will improve their knowledge. The investigators also want to know if this knowledge lasts over time. Right now there are few medication instructional cards that are appropriate for children. Most of the medication cards provide information for adults. Some studies have shown that by teaching children directly, the children may take medicine at the right time for the right reason, have fewer side effects and know more about their medicine. The purpose of this research study is to see if education about medication helps children learn more about their medicine and if this knowledge lasts.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Blood Coagulation Disorders | — | UNRESOLVED | — |
| Hemophilia | — | UNRESOLVED | — |
| Neoplasms | Neoplasm | ONTOLOGY_EXACT | 0.90 |
| Sickle Cell Disease | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Medication Education for Children | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Develop medication cards appropriate for children
- measure
- Develop a post-test to determine the effectiveness
- measure
- Obtain data to support teaching children about medication
Secondary outcomes (1)
- measure
- Assess the clinical implications of this research
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 7 Years
- Maximum age
- 11 Years
Show eligibility criteria text
Inclusion Criteria: * Between the ages of 7 - 11 years * Currently receiving disease management primarily coordinated through the Hematology/Oncology section * Receiving a medication identified as a variable for this study * Are able to assent and have a parent/guardian who is willing to consent to study participation * Suffer no apparent developmental difficulty that would prevent or make study participation difficult Exclusion Criteria: * Individuals who cannot read or write English * Individuals who are known to be non-compliant with medication routine and/or adhering to follow-up visits.
References
Publications (0)
Data not yet available